KENT Nutrition began with a blunt promise - no filler. Nearly a century later, the family-owned Iowa business tests feed on an 800-acre research farm and sells hundreds of formulas for animals ranging from feedlot cattle to backyard rabbits.
Novozymes and Chr. Hansen spent a century turning bacteria and enzymes into industrial ingredients. In 2024 they became one company - and quietly one of the biggest biotech businesses you have never heard of.
CJ CheilJedang turned Korean pantry staples into a global frozen-food business. Behind the dumplings is a second company built on fermentation, amino acids and a bet that microbes can make better materials.
Champion Petfoods turned a simple premise - put more recognizable animal ingredients into the bowl - into two global premium brands. Four decades in, the Mars-owned company is betting that the next contest in pet food will be won in the pilot kitchen as much as the pet-store aisle.
The company you have never heard of is inside almost everything you eat. Here is how a linseed-crushing shop from 1902 became the invisible spine of the global food supply.
Number 8 Bio is a Sydney-based agtech and climate startup building BetterFeed, a low-cost feed additive and slow-release rumen bolus that cuts enteric methane from cattle and sheep by up to 90% in trials while recapturing wasted feed energy to lift animal productivity. After pivoting from yeast biomanufacturing to synthetic-chemistry small molecules, the company targets grass-fed grazing systems - about 95% of Australia's livestock - and has raised roughly A$18 million to move toward commercial release.
Calysta is a San Mateo, California biotechnology company that uses a patented gas-fermentation platform to turn methane into FeedKind, a single-cell protein for aquaculture, livestock and pet feed - and increasingly human food. Its bacteria eat natural gas instead of arable land, plants or animals, producing protein with a low environmental footprint. Backed by Cargill, BP and Temasek and partnered with Adisseo through the Calysseo joint venture, Calysta opened the world's first industrial-scale single-cell protein plant in Chongqing, China in 2022.